BCL2 and acute kidney injury: Together, our study provides evidence that urinary miR-16 level is upregulated by the C/EBP-β-miR-16-BCL2 axis, which forms the molecular basis for AKI, and increased urinary miR-16 level may provide information in designing a strategy for the treatment of AKI.